Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy
X-linked myotubular myopathy (XLMTM) is a fatal congenital disorder caused by mutations in the MTM1 gene. Currently, there are no approved treatments, although AAV8-mediated gene transfer therapy has shown promise in animal models and preliminarily in patients. However, 4 patients with XLMTM treated...
Main Authors: | Sophie Karolczak, Ashish R. Deshwar, Evangelina Aristegui, Binita M. Kamath, Michael W. Lawlor, Gaia Andreoletti, Jonathan Volpatti, Jillian L. Ellis, Chunyue Yin, James J. Dowling |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-09-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI166275 |
Similar Items
-
ERRγ suppression by Sirt6 alleviates cholestatic liver injury and fibrosis
by: Lihua Hao, et al.
Published: (2020-12-01) -
X‐linked myotubular myopathy associated with an MTM1 variant in a Maine coon cat
by: Matthew A. Kopke, et al.
Published: (2022-09-01) -
X-linked Myotubular Myopathy with a Novel MTM1 Mutation in a Taiwanese Child
by: Chia-Ying Chang, et al.
Published: (2008-12-01) -
Centronuclear (myotubular) myopathy
by: Wallgren-Pettersson Carina, et al.
Published: (2008-09-01) -
Natural history of a mouse model of X-linked myotubular myopathy
by: Ege Sarikaya, et al.
Published: (2022-07-01)